All data are based on the daily closing price as of February 5, 2026
c

Center Laboratories

4123.TWO
1.25 USD
-0.02
-1.57%

Overview

Last close
1.25 usd
Market cap
922.00M usd
52 week high
1.59 usd
52 week low
0.93 usd
Target price
N/A usd

Valuation

P/E
18.1651
Forward P/E
N/A
Price/Sales
18.67
Price/Book Value
1.4825
Enterprise Value
1.03B usd
EV/Revenue
20.5658
EV/EBITDA
12.6377

Key financials

Revenue TTM
49.38M usd
Gross Profit TTM
20.97M usd
EBITDA TTM
9.21M usd
Earnings per Share
0.07 usd
Dividend
0.02 usd
Total assets
846.79M usd
Net debt
128.61M usd

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei City
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top